Valuation: MRI Interventions Inc

Market Cap 45Cr 39Cr 37Cr 34Cr 63Cr 4.35TCr 64Cr 436.78Cr 170.95Cr 2.13TCr 169.2Cr 165.56Cr 7.35TCr P/E 2026 *
-13.5x
P/E 2027 * -16x
Enterprise Value 45Cr 39Cr 37Cr 34Cr 63Cr 4.35TCr 64Cr 436.78Cr 170.95Cr 2.13TCr 169.2Cr 165.56Cr 7.35TCr EV / Sales 2026 *
8.48x
EV / Sales 2027 * 7.03x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 49 07/11/2017
Director of Finance/CFO 41 01/01/2021
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 68 10/03/2014
Chairman 80 04/02/2021
Director/Board Member 49 07/11/2017
Change 5-day change 1-year change 3-year change Capi.($)
+24.88%-8.05% - - 45Cr
+9.52%+5.92%+23.28%+0.67% 20TCr
+5.93%-8.04%-4.73%-26.92% 13TCr
-3.04%-17.77%-34.09%+2.24% 12TCr
+0.77%-2.90%-59.79%-16.95% 6.39TCr
-0.40%-4.17%+9.45%-7.90% 4.86TCr
-1.69%-3.10%-26.76%-33.51% 4.39TCr
+4.31%+1.86%+16.04%+8.55% 3.77TCr
+3.09%+0.46%+28.52%+32.40% 3.64TCr
+2.82%+3.05%+87.41%+4.24% 2.89TCr
Average +4.50%-3.39%+4.37%-4.13% 7.79TCr
Weighted average by Cap. +3.52%-4.99%-0.73%-6.14%

Financials

2026 *2027 *
Net sales 5.31Cr 4.66Cr 4.32Cr 3.97Cr 7.48Cr 512.71Cr 7.59Cr 51Cr 20Cr 250.88Cr 20Cr 20Cr 866.65Cr 6.41Cr 5.62Cr 5.21Cr 4.79Cr 9.03Cr 618.53Cr 9.16Cr 62Cr 24Cr 302.66Cr 24Cr 24Cr 1.05TCr
Net income -3.31Cr -2.9Cr -2.69Cr -2.47Cr -4.66Cr -319.08Cr -4.73Cr -32Cr -13Cr -156.13Cr -12Cr -12Cr -539.35Cr -2.86Cr -2.51Cr -2.33Cr -2.14Cr -4.03Cr -276.3Cr -4.09Cr -28Cr -11Cr -135.2Cr -11Cr -11Cr -467.04Cr
Net Debt - -
Logo MRI Interventions Inc
ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-